• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产碳青霉烯酶肺炎克雷伯菌的控制:区域范围的干预措施。

Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention.

机构信息

Agenzia Sanitaria e Sociale Regionale Emilia-Romagna, Bologna, Italy.

出版信息

Euro Surveill. 2014 Oct 30;19(43):20943. doi: 10.2807/1560-7917.es2014.19.43.20943.

DOI:10.2807/1560-7917.es2014.19.43.20943
PMID:25375901
Abstract

Starting in 2010, there was a sharp increase in infections caused by Klebsiella pneumoniae resistant to carbapenems in the Emilia-Romagna region in Italy. A region-wide intervention to control the spread of carbapenemase-producing K. pneumoniae (CPKP) in Emilia-Romagna was carried out, based on a regional guideline issued in July 2011. The infection control measures recommended to the Health Trusts (HTs) were: phenotypic confirmation of carbapenemase production, active surveillance of asymptomatic carriers and contact isolation precautions for carriers. A specific surveillance system was activated and the implementation of control measures in HTs was followed up. A significant linear increase of incident CPKP cases over time (p<0.001) was observed at regional level in Emilia-Romagna in the pre-intervention period, while the number of cases remained stable after the launch of the intervention (p=0.48). Considering the patients hospitalised in five HTs that provided detailed data on incident cases, a downward trend was observed in incidence after the release of the regional guidelines (from 32 to 15 cases per 100,000 hospital patient days). The spread of CPKP in Emilia-Romagna was contained by a centrally-coordinated intervention. A further reduction in CPKP rates might be achieved by increased compliance with guidelines and specific activities of antibiotic stewardship.

摘要

自 2010 年以来,意大利艾米利亚-罗马涅地区耐碳青霉烯类肠杆菌科细菌(Carbapenem-Resistant Enterobacteriaceae,CRE)感染急剧增加。艾米利亚-罗马涅地区根据 2011 年 7 月发布的区域指南,开展了一项控制产碳青霉烯酶肺炎克雷伯菌(Carbapenemase-producing Klebsiella pneumoniae,CPKP)传播的区域干预措施。向卫生信托基金(Health Trusts,HTs)推荐的感染控制措施包括:表型确证碳青霉烯酶的产生、对无症状携带者进行主动监测以及对携带者进行接触隔离预防措施。激活了一个特定的监测系统,并对 HTs 中控制措施的实施情况进行了跟踪。在艾米利亚-罗马涅地区,在干预前期间,观察到区域水平的 CPKP 病例呈显著线性增加(p<0.001),而在干预启动后,病例数量保持稳定(p=0.48)。在提供关于偶发病例详细数据的五家 HTs 中考虑住院患者,在发布区域指南后,发病率呈下降趋势(从每 100,000 名住院患者日 32 例降至 15 例)。通过集中协调的干预措施,控制了 CPKP 在艾米利亚-罗马涅地区的传播。通过提高指南的依从性和开展特定的抗生素管理活动,可能进一步降低 CPKP 的发生率。

相似文献

1
Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention.产碳青霉烯酶肺炎克雷伯菌的控制:区域范围的干预措施。
Euro Surveill. 2014 Oct 30;19(43):20943. doi: 10.2807/1560-7917.es2014.19.43.20943.
2
Imported Klebsiella pneumoniae carbapenemase-producing K. pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination.希腊某医院产碳青霉烯酶肺炎克雷伯菌克隆株的输入:感染控制措施对遏制其传播的影响。
J Clin Microbiol. 2012 Aug;50(8):2618-23. doi: 10.1128/JCM.00459-12. Epub 2012 May 30.
3
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy.意大利布雷西亚医院产KPC-3的耐碳青霉烯类肺炎克雷伯菌菌株的出现。
New Microbiol. 2014 Apr;37(2):177-83. Epub 2014 Apr 1.
4
Infections Caused by Carbapenemase-Producing Klebsiella pneumoniae: Microbiological Characteristics and Risk Factors.产碳青霉烯酶肺炎克雷伯菌引起的感染:微生物学特征及危险因素
Microb Drug Resist. 2019 Mar;25(2):287-296. doi: 10.1089/mdr.2018.0339. Epub 2019 Feb 27.
5
Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit.产碳青霉烯酶肺炎克雷伯菌的传播动力学及其在外科单元中感染控制策略的预期影响。
PLoS One. 2012;7(7):e41068. doi: 10.1371/journal.pone.0041068. Epub 2012 Jul 31.
6
Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.2014-2016 年斯洛文尼亚成功控制首例 OXA-48 和/或 NDM 碳青霉烯酶产生的肺炎克雷伯菌爆发
J Hosp Infect. 2019 Feb;101(2):142-149. doi: 10.1016/j.jhin.2018.10.022. Epub 2018 Nov 3.
7
Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy.意大利产 KPC-3 型肺炎克雷伯菌爆发的控制。
J Clin Microbiol. 2011 Nov;49(11):3986-9. doi: 10.1128/JCM.01242-11. Epub 2011 Sep 7.
8
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.意大利一家医院成功控制耐碳青霉烯类肺炎克雷伯菌暴发及感染防控
New Microbiol. 2014 Jan;37(1):87-90. Epub 2014 Jan 15.
9
Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures.通过对患者进行分组并加强感染控制措施,重症监护病房产超广谱β-内酰胺酶肺炎克雷伯菌的暴发得到了控制。
Infect Control Hosp Epidemiol. 2008 Jun;29(6):517-24. doi: 10.1086/588004.
10
Using an intensified infection prevention intervention to control carbapenemase-producing Enterobacteriaceae at a Thai center.在泰国一家医疗中心采用强化感染预防干预措施来控制产碳青霉烯酶肠杆菌科细菌。
Infect Control Hosp Epidemiol. 2012 Sep;33(9):960-1. doi: 10.1086/667386.

引用本文的文献

1
Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China.中国某地区产碳青霉烯酶肠杆菌科细菌的克隆传播。
BMC Microbiol. 2022 Mar 29;22(1):81. doi: 10.1186/s12866-022-02497-y.
2
Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.在流行地区含有产碳青霉烯酶肺炎克雷伯菌。
Antimicrob Resist Infect Control. 2020 Jul 6;9(1):102. doi: 10.1186/s13756-020-00766-x.
3
Carbapenem-resistant -impact of infection-prevention and control interventions.耐碳青霉烯类药物——感染预防与控制干预措施的影响
Ann Transl Med. 2019 Dec;7(Suppl 8):S344. doi: 10.21037/atm.2019.09.91.
4
Spread of Carbapenem-Resistant in Hub and Spoke Connected Health-Care Networks: A Case Study from Italy.碳青霉烯类耐药菌在轴心辐射式连接的医疗保健网络中的传播:来自意大利的案例研究
Microorganisms. 2019 Dec 23;8(1):37. doi: 10.3390/microorganisms8010037.
5
Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.高流行地区碳青霉烯类耐药肠杆菌科细菌定植筛查:意大利 CRE 感染工作组立场文件。
Antimicrob Resist Infect Control. 2019 Aug 13;8:136. doi: 10.1186/s13756-019-0591-6. eCollection 2019.
6
Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.实体器官移植中耐碳青霉烯类肠杆菌科细菌:管理原则
Curr Infect Dis Rep. 2019 Jun 10;21(7):26. doi: 10.1007/s11908-019-0679-4.
7
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant : a 4-year quasi-experimental before-and-after study.感染预防和控制干预措施以减少 ICU 获得性耐碳青霉烯类肠杆菌科细菌定植和感染:一项为期 4 年的准实验前后研究。
Antimicrob Resist Infect Control. 2019 Jan 10;8:8. doi: 10.1186/s13756-018-0453-7. eCollection 2019.
8
Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.医疗机构中碳青霉烯类耐药肠杆菌科、鲍曼不动杆菌和铜绿假单胞菌的控制:一项系统评价和准实验研究的重新分析。
Clin Infect Dis. 2019 Feb 15;68(5):873-884. doi: 10.1093/cid/ciy752.
9
A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.碳青霉烯类耐药肠杆菌科的临床流行病学系统评价和荟萃分析。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01730-17. Print 2018 Jan.
10
Epidemiology and biomolecular characterization of carbapenem-resistant in an Italian hospital.意大利一家医院耐碳青霉烯类药物的流行病学及生物分子特征分析
J Prev Med Hyg. 2016 Sep;57(3):E149-E156.